Page template : single.php
Search terms : 
Sort : 
Page : 0

Dr. Nick Bansback recognized for his work in health technology assessment

CADTH 2016_Symp_652x400
Dr. Nick Bansback (left) with Brian O’Rourke, CADTH President and Chief Executive Officer, at CADTH’s 2016 Symposium. | PHOTO COURTESY OF CADTH

Congratulations to CHÉOS Scientist Dr. Nick Bansback, who has received this year’s Maurice McGregor Award from CADTH.

Dr. Bansback’s research aims to inform policies and practices in health through the application of health economics and decision theory. He has published widely in the use of preference-based instruments such as the EQ-5D, conducted numerous economic evaluations in rheumatology and is currently focusing his research on improving decision-making at the patient/physician consultation using decision support tools.

This award was established in 2014 to recognize rising health technology assessment (HTA) stars early in their careers, and is named in honour of Dr. Maurice McGregor, retired Chair of the Technology Assessment Unit of the McGill University Health Centre and Professor Emeritus of McGill University. Affectionately known to his colleagues as the “grandfather of HTA in Canada,” Dr. McGregor was also appointed Officer of the Order of Canada for having pioneered and championed the field of HTA in Canada and for his leadership in medical education and cardiology.

Dr. Bansback will be formally presented with his award at the 2016 CADTH Symposium. This year’s symposium takes place April 10 to 12 in Ottawa, and the theme for this year’s event is “Evidence for Everyone: Expanding the Reach of Health Technology Assessment.”

He and his fellow CHÉOS investigators Drs. Aslam Anis, Mark Harrison, Larry Lynd, and Wei Zhang are presenting at the symposium.

Congrats, Nick!

—-

Abstracts:

Zhang W, Anis A. How to measure and value work productivity loss due to illness. CADTH 2016 Symposium. Ottawa, ON; April 10–12, 2016. Workshop AM-3.

Lynd L, Coyle D, Evans G, Lun E, Tam R. Exploring contemporary pressures on pharmaceutical reimbursement in an era of orphan drugs and personalized medicine. CADTH 2016 Symposium. Ottawa, ON; April 10–12, 2016. Concurrent Session A6 – Panel Discussion.

Bansback N, Pechlivanoglou P, Cameron C, Kanters S, Veroniki AA. New methods in generating evidence for everyone: Can we improve evidence synthesis approaches? CADTH 2016 Symposium. Ottawa, ON; April 10–12, 2016. Concurrent Session C4 – Panel Discussion.

Harrison M, Bansback N, Marshall D, Bryan S. The contribution of patient-reported outcome measures to health care sustainability. CADTH 2016 Symposium. Ottawa, ON; April 10–12, 2016. Concurrent Session E5 – Panel Discussion.

Health research in the heart of Vancouver